1-5 of 5
Tracey Chinn, RN
Close
Sort by
Journal Articles

FLT Imaging Reveals Kinetics and Biology of Engraftment after Myeloablative HSCT

Kirsten M Williams, MD, Jennifer L. Holter Chakrabarty, MD, Liza Lindenberg, MD, Steve Adler, Juan Gea-Banacloche, MD, Bazetta Blacklock-Schuver, RN, Frances T. Hakim, PhD, Dennis D. Hickstein, MD, James N Kochenderfer, MD, Jennifer Wilder, Tracey Chinn, RN, Karen Kurdziel, MD, Seth M. Steinberg, PhD, Hanh Khuu, Frank I Lin, Daniel H. Fowler, MD, David Halverson, MD, Daniele N. Avila, CRNP, George Selby, MD, Tiffani N. Taylor, PA, Jennifer Mann, Jennifer Hsu, RN, Robert B. Epstein, MD, Stacy L Anderson, Nguyen Chuong, Joseph Havlicek, Shibo Li, MD, Tom Pham, Teresa Kraus, Sara K. Vesely, PhD MPH, Steven Z. Pavletic, MD, Catherine M. Bollard, MBChB, MD, Peter Choyke, MD, Ronald E Gress, MD
Journal: Blood
Blood (2014) 124 (21): 1147.
https://doi.org/10.1182/blood.V124.21.1147.1147
Published: 2014
Journal Articles

Comparison of Empiric Versus Prophylactic Administration of Ceftazidime during Neutropenia Associated with Reduced-Intensity Allogeneic Stem Cell Transplantation (RIST).

Kyle M. Donley, Juan C. Gea-Banacloche, MD, Robert M. Dean, MD, Seth M. Steinberg, PhD, Richard W. Childs, MD, Jeanne Odom, RN, Kathleen Castro, RN, Tracey Chinn, RN, Daniel H. Fowler, MD, Michael R. Bishop, MD
Journal: Blood
Blood (2004) 104 (11): 5100.
https://doi.org/10.1182/blood.V104.11.5100.5100
Published: 2004
Journal Articles

Immunotherapy and Chemotherapy Can Result in Long-Term Survival for Patients with Recurrent or Progressive Non-Hodgkin’s Lymphoma after Reduced-Intensity Allogeneic Stem Cell Transplantation.

Michael R. Bishop, MD, Robert M. Dean, MD, Wyndham H. Wilson, MD, PhD, Jeanne Odom, RN, Seth Steinberg, PhD, Michael Krumlauf, RN, Claude Kasten-Sportes, MD, Steven Z. Pavletic, MD, Kathleen Castro, RN, Tracey Chinn, RN, Ronald Gress, MD, Daniel H. Fowler, MD
Journal: Blood
Blood (2004) 104 (11): 1643.
https://doi.org/10.1182/blood.V104.11.1643.1643
Published: 2004
Journal Articles

Immunoablative Chemotherapy before Reduced-Intensity Allogeneic Stem Cell Transplantation: A Strategy to Provide Disease Control and to Enhance Early Graft-Versus-Lymphoma Effects.

Robert M. Dean, MD, Daniel H. Fowler, MD, Frances T. Hakim, PhD, Jeanne Odom, RN, Kathleen Castro, RN, Tracey Chinn, RN, Wyndham H. Wilson, MD, PhD, Ronald E. Gress, MD, Michael R. Bishop, MD
Journal: Blood
Blood (2004) 104 (11): 1829.
https://doi.org/10.1182/blood.V104.11.1829.1829
Published: 2004
Journal Articles

Engraftment Syndrome after Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: Impact of Graft-Versus-Host Disease Prophylaxis and T Cell Dose.

Robert M. Dean, MD, Kyle M. Donley, BA, Juan Gea-Banacloche, MD, Seth M. Steinberg, PhD, Jeanne Odom, RN, Michael Krumlauf, RN, Kathleen Castro, RN, Tracey Chinn, RN, Daniel H. Fowler, MD, Ronald E. Gress, MD, Michael R. Bishop, MD
Journal: Blood
Blood (2004) 104 (11): 5052.
https://doi.org/10.1182/blood.V104.11.5052.5052
Published: 2004